论文部分内容阅读
目的:探讨痰热清注射液治疗小儿上呼吸道感染伴发烧的临床疗效。方法:接收在我院进行治疗的上呼吸道感染伴发烧的患儿一共有94例,随机分为观察组、对照组,对照组对患儿采取双黄连注射液进行治疗,观察组对患儿采取痰热清注射液进行治疗,对比两组患儿的治疗效果。结果:观察组患儿的治疗效果显著优于对照组,其之间的差异具有统计学意义(P<0.05);观察组患儿的退烧起效时间和药物止咳起效时间明显低于对照组,其之间的差异具有统计学意义(P<0.05);观察组患儿的不良反应发生率明显低于对照组,其之间的差异具有统计学意义(P<0.05)。结论:小儿上呼吸道感染伴发烧采取痰热清注射液进行治疗的效果可靠,起效迅速,不良反应较少,具有较高的临床应用价值。
Objective: To investigate the clinical efficacy of Tanreqing Injection in treating pediatric upper respiratory tract infection with fever. Methods: A total of 94 children with upper respiratory tract infection and fever who were treated in our hospital were randomly divided into observation group, control group and control group. Shuanghuanglian injection was used to treat children. The observation group took Tanreqing injection for treatment, the treatment of children with two groups compared. Results: The therapeutic effect of the observation group was significantly better than that of the control group, the difference was statistically significant (P <0.05); the onset of fever and onset of anti-cough in the observation group were significantly lower than those in the control group (P <0.05). The incidence of adverse reactions in the observation group was significantly lower than that in the control group, and the difference was statistically significant (P <0.05). Conclusion: Pediatric upper respiratory tract infection with Tanreqing injection is reliable and has rapid onset of action with few adverse reactions and high clinical value.